Rchr
J-GLOBAL ID:201601002622284380   Update date: Oct. 30, 2024

Miyamoto Yoichi

ミヤモト ヨウイチ | Miyamoto Yoichi
Affiliation and department:
Job title: Chief Researcher
Research field  (4): Zoological sciences ,  Molecular biology ,  Medical biochemistry ,  Cell biology
Research keywords  (8): 細胞核 ,  核タンパク質輸送 ,  Importin ,  ヌクレオポリン ,  感染症 ,  Spermatogenesis ,  Cancer ,  ストレス応答
Research theme for competitive and other funds  (15):
  • 2024 - 2027 微小核の本態解明を目指したImportin-α1の新機能探索
  • 2022 - 2025 Exploring a novel function of nuclear transport molecules in male and female gametogenesis and elucidation of the infertility mechanism
  • 2020 - 2024 Elucidation of protein translation shutoff by mosquito-borne flavivirus
  • 2022 - 2024 フラビウイルス構成因子の核輸送機構の分子理解と創薬展開
  • 2020 - 2023 フラビウイルスの生活環に特異的な抗フラビウイルス薬の創出
Show all
Papers (69):
  • Koki Sakurai, Makiko Morita, Yoshiatsu Aomine, Mitsunobu Matsumoto, Tetsuji Moriyama, Emiko Kasahara, Atsuo Sekiyama, Mayumi Otani, Rieko Oshima, Kate L Loveland, et al. Importin α4 deficiency induces psychiatric disorder-related behavioral deficits and neuroinflammation in mice. Translational psychiatry. 2024. 14. 1. 426-426
  • miR-147-3p in pathogenic CD4+ T cells controls chemokine receptor expression for the development of experimental autoimmune diseases. Journal of Autoimmunity. 2024. 149. 103319
  • Yumi Itoh, Yoichi Miyamoto, Makoto Tokunaga, Tatsuya Suzuki, Akira Takada, Akinori Ninomiya, Tomomi Hishinuma, Mami Matsuda, Yoshihiro Yoneda, Masahiro Oka, et al. Importin-7-dependent nuclear translocation of the Flavivirus core protein is required for infectious virus production. PLOS Pathogens. 2024. 20. 8. e1012409
  • Norifumi Iijima, Tomoya Hayashi, Masaaki Niino, Yoichi Miyamoto, Masahiro Oka, Ken J Ishii. Tridecylcyclohexane in incomplete Freund's adjuvant is a critical component in inducing experimental autoimmune diseases. European journal of immunology. 2024. e2350957
  • Hirotaka Nomiya, Koki Sakurai, Yoichi Miyamoto, Masahiro Oka, Yoshihiro Yoneda, Takatoshi Hikida, Masami Yamada. A Kpna1-deficient psychotropic drug-induced schizophrenia model mouse for studying gene-environment interactions. Scientific Reports. 2024. 14. 1
more...
MISC (7):
more...
Books (1):
  • 決定版 阻害剤・活性化剤ハンドブック
    羊土社 2019
Lectures and oral presentations  (29):
  • A Novel Role of Importin α in the Micronucleus and Its Physiological Significance
    (15th International Conference on Nucleocytoplasmic Transport 2024)
  • 微小核における核輸送分子Importin-α1の新機能とがんにおける病態的意義
    (第83回日本癌学会学術総会 2024)
  • A novel function of the nuclear transport factor Importin α1 in the micronuclei.
    (2024)
  • Functional Significance of Importin Alpha in the Testis and Brain
    (The 27th North American Testis Workshop, Denver, Colorado 2024)
  • A novel functional aspect of Importin α in micronuclei
    (RIKEN International Symposium on Nuclear Structure and Function 2024 2024)
more...
Education (3):
  • 1997 - 2001 Osaka University
  • 1995 - 1997 Osaka University
  • 1991 - 1995 University of Miyazaki Faculty of Agriculture
Professional career (1):
  • 博士(医学) (大阪大学)
Work history (10):
  • 2024/04 - 現在 National Institutes of Biomedical Innovation, Health and Nutrition Laboratory of Biofunctional Molecular Medicine, Center for Drug Design Research Chief Research Scientist
  • 2023/04 - 2024/03 National Institutes of Biomedical Innovation, Health and Nutrition Laboratory of Nuclear Transport Dynamics, Center for Drug Design Research Chief Research Scientist
  • 2015/04 - 2023/03 National Institutes of Biomedical Innovation, Health and Nutrition Laboratory of Nuclear Transport Dynamics Sub-project leader
  • 2014/05 - 2015/03 National Institute of Biomedical Innovation Laboratory of Nuclear Transport Dynamics Sub-project leader
  • 2013/01 - 2014/04 Monash University Research Fellow
Show all
Association Membership(s) (4):
JAPAN SOCIETY FOR CELL BIOLOGY ,  THE JAPANESE BIOCHEMICAL SOCIETY ,  THE MOLECULAR BIOLOGY SOCIETY OF JAPAN ,  日本癌学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page